Lysando AG, which is developing technology to fight microbial infections, has appointed Leonhard Stärk to a new ethics committee which will guide it on the introduction of a product for gonorrhoea. He will be joined on the committee by Karl Liese. Both men will serve on a voluntary basis. Mr Stark has been the regional manager of the Bavarian Red Cross since 2007, while Dr Liese is senior partner for global healthcare with McKinsey & Company. Lysando has developed what it says is a resistance stable product to fight gonorrhoea.
Lysando announced the appointment on 16 September 2019.
Copyright 2019 Evernow Publishing Ltd